Home Alzheimer’s Disease Detection Rate of SARS-COV2 Antibodies After COVID-19 in Patients with Cancer

Detection Rate of SARS-COV2 Antibodies After COVID-19 in Patients with Cancer

Results from an analysis published in Annals of Oncology, which included both patients with cancer and healthcare workers at Centre Léon Bérard in Lyon, France, demonstrated that patients with cancer had a significantly lower detection rate of SARS-COV2 antibodies 15 days or later after coronavirus disease 2019 (COVID-19) symptoms and RT-PCR-positive test than healthcare workers.1

“[Patients with cancer] had a significantly lower detection rate of SARS-COV2 antibodies 15 days or later after symptoms and RT-PCR+ testing,” the study authors wrote. “Anti-SARS-COV2 [antibodies] were more often undetectable in patients receiving cancer treatments in the month prior to testing.”

In this study, researchers retrospectively analyzed patients with cancer presenting with a suspicion of COVID-19 from March 1, 2020 to April 16, 2020 as part of an Institutional Review Board approved…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Cancer and Mental Health Re-post : braincancer

Hello!I would like to thank everyone who participated in my survey these past few months! I received a tremendous response and I truly, truly...

I put my feelings in music. : braincancer

Song LinkHi amigos. My 2year old son has been battling cancer for nearly 6 months and this song is just a expression of my...

Podcast Episode Interviewing Brain Cancer Fighter & Survivor : braincancer

Hi all, we have a podcast called Making Headway that is meant as a support for brain injury survivors. My co-host, Eryn, and I...

How has COVID-19 affected the global cancer community? – IBTA

Save the date: Coalition Connection: COVID-19 on 4 February 06:30am PST/ 09:30am EST/ 02:30pm GMT/ 03:30pm CET On 4th February 2021, the Global Cancer Coalition Network...

Recent Comments